Illustration: Aïda Amer/Axios

Dentists' offices are reopening and working overtime, and dental suppliers are optimistic things are close to returning to normal after the coronavirus put the industry on ice for almost two months.

Why it matters: Cleaning teeth and filling cavities, by their nature, require close contact with the vessel that spreads the virus. That has some experts worried, and the World Health Organization this month advised people to delay routine dental care until COVID-19 transmission rates decline further.

Driving the news: Almost every part of the dental industry lost money and shed jobs during the lockdowns, but people are making appointments and buying products again.

  • Almost all dentist offices are open now. Revenues are still expected to fall by 40% this year.
  • Global dental supply sales at Henry Schein, a supply distributor, dropped 41% in the second quarter. But Henry Schein CFO Steven Paladino told investors this month that "in the states in the U.S. that are showing an increased infection rate for COVID, we're not seeing any significant falloff in patient demand."
  • Sales at dental equipment manufacturer Dentsply Sirona plummeted 51%. Dental patients are returning at a gradual pace, executives said, and July volumes were looking better than June.
  • Sales at Align Technology, which makes Invisalign teeth straighteners, fell 41% in the second quarter. Align CEO Joseph Hogan told investors he was "incredibly optimistic ... we don't see another COVID shutdown on a major market that lasts a long period of time," and the company is trying to reach more teens during the pandemic by signing a promotional deal with social media influencer Charli D'Amelio.

Between the lines: Just like large medical insurers, fewer people visiting their dentist has been a boon for dental insurers.

  • However, deferring dentist appointments is leading to emergency procedures, and "we fully expect" to see more of that this year, said David Holmberg, CEO of Highmark Health, which owns United Concordia Dental.

The big picture: Federal health officials have not documented any COVID-19 cases within dentists' offices.

  • The Centers for Disease Control and Prevention consequently isn't matching WHO's call to postpone routine services, but the agency is telling dentists to provide care "only after you have assessed the patient and considered both the risk to the patient of deferring care and the risk" to staff and patients of transmitting the virus.

The bottom line: Dentists and hygienists have more protective equipment now than they did early on, but oral care will be the first health service to get paused again if outbreaks continue to worsen.

Go deeper

Updated Sep 16, 2020 - Health

Top HHS spokesperson takes leave of absence after accusing scientists of "sedition"

Michael Caputo in Washington, D.C. in May 2018. Photo: Mark Wilson/Getty Images

Department of Health and Human Services spokesperson Michael Caputo is taking a 60 day leave of absence "to focus on his health and the well-being of his family," the agency said in a statement on Wednesday.

Driving the news: Caputo baselessly accused career scientists at the Centers for Disease Control and Prevention in a Facebook livestream on Sunday of gathering a "resistance unit" for "sedition" against President Trump, the New York Times reported on Tuesday. He apologized to staff on Tuesday, according to Politico.

Coronavirus cases increase in 17 states

Expand chart
Data: The COVID Tracking Project, state health departments; Map: Andrew Witherspoon, Sara Wise/Axios

Coronavirus infections ticked up slightly over the past week, thanks to scattered outbreaks in every region of the country.

Where it stands: The U.S. has been making halting, uneven progress against the virus since August. Overall, we're moving in the right direction, but we're often taking two steps forward and one step back.

23 hours ago - Health

The risks of moving too fast on a coronavirus vaccine

Illustration: Sarah Grillo/Axios

The scientific race for a coronavirus vaccine is moving at record-shattering speed. Making the most of that work — translating a successful clinical product into real-world progress — will require some patience.

Why it matters: If we get a vaccine relatively soon, the next big challenge will be balancing the need to get it into people's hands with the need to keep working on other solutions that might prove more effective.